Report
Eurofins : Investors’ day London: a temporary soft patch in Q3/Q4, confidence expressed for 2025 and beyond
>Update on the key messages by division - Biopharma: the group has lost two major contracts (due to the success of clinical testing which has enabled clients to move the later stages more rapidly than expected, not due to any calling into question of Eurofins), and a third contract that has been significantly reduced for similar reasons. The group stressed that new major contracts should take over in H2 2025. In agriscience, management acknowledged the weak visibility...
Underlying
Eurofins Scientific Societe Europeenne
Provider
Oddo BHF
Oddo Securities provides securities brokerage and research services. The company offers equity, economic, and derivatives research and credit analysis services. It focuses on insurance, automotive, building materials, pharmaceuticals, telecommunications, information technology, and agri-food industries.
Geoffroy Michalet
Other Reports on these Companies
Other Reports from Oddo BHF
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.